Discover 1,934 paid clinical trials in Hialeah, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,934
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
for
Alzheimer's Disease
Location: Wellington FL, Fort Myers FL, Sarasota FL, Tampa FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 60 - 70+
Code: NCT06976203
Phase 3, Recruiting
Empathic Communication Skills (ECS) Training
for
Lung Cancer
Location: Miami FL, Chesapeake VA, Philadelphia PA, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT05456841
Recruiting
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
for
Major Depressive Disorder (MDD),
Location: Lauderhill FL, West Palm Beach FL, Palm Bay FL,
Sponsor: Seaport Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07065240
Phase 2, Recruiting
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
for
HPV-Related Squamous Cell Carcinoma
Location: Miami FL, Middletown NJ, Basking Ridge NJ, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06563479
Phase 3, Recruiting
New
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or Overweight
for
Chronic Weight Management
Location: South Miami FL
Sponsor: Ascletis Pharma (China) Co., Limited
Sex: All
Age: 18 - 65
Code: NCT07893106
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of ALTO-101 in Patients With Schizophrenia
for
Schizophrenia, Cognitive Impairment
Location: Hollywood FL, Tampa FL, Snellville GA, Gaithersburg MD,
Sponsor: Alto Neuroscience
Sex: All
Age: 21 - 55
Code: NCT06502964
Phase 2, Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Location: Pembroke Pines FL, Englewood FL, Lady Lake FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06679101
Phase 3, Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Pembroke Pines FL, Miami FL, Hollywood FL, Augusta GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06672146
Phase 2, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies
for
Mature B-cell Malignancies
Location: Plantation FL, Westbury NY
Sponsor: InnoCare Pharma Inc.
Sex: All
Age: 18+
Code: NCT06351527
Phase 1, Recruiting
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts